Previous 10 | Next 10 |
Summary Doximity is a rare IT vendor who reported positive business trends when it released its Q3 results at the start of November, 2022. The company's big pharma and hospital customers showed increased appetite for Doximity solutions. The company is one of the most profitable IT v...
Summary The adoption of digital tools to increase productivity in the healthcare sector has been gradual. Doximity's product line-up caters to every link in the value chain. DOCS has the most extensive network of medical professionals. Description I recommend buying Do...
If you can get your portfolio to $1 million, that can make it a whole lot easier to live off your investments and reduce how much you need to work or to retire early. To achieve that, you'll need to find quality stocks that can generate strong gains over the years. Today, I'll look at whether...
If you've been paying attention, 2022 has been a lousy year for digital advertisers. During the second quarter and again in the third, Meta Platforms , parent of Facebook and Instagram, reported declining ad revenue for the first time since its initial public offering. The drama at Facebo...
Whether your retirement is looming on the horizon or many decades away, it's always a good time to be planning for a more financially free future. Constructing a robust, long-term investment portfolio is a key element of building out a sustainable and profitable retirement plan. If you've set...
Shares of Doximity (NYSE: DOCS) shot 28.4% higher last month after it reported quarterly earnings. The telehealth company's revenue grew 29% year over year, beating Wall Street's estimates for both sales and profits. It also provided positive forward-looking commentary on its advertis...
Shares of Doximity (NYSE: DOCS) closed on Thursday at $34.78, down 9.9% for the week so far, according to data from S&P Global Intelligence . The digital platform for healthcare professionals fell as much as 11.6% for the week but bounced back a bit on Thursday. The stock closed ...
Ever since Doximity (NYSE: DOCS) went public in June 2021, the stock has been commanding a significant premium. Unsurprisingly, as investors have become more focused on valuations and earnings multiples, shares of Doximity have been falling in value and are down 38% year to date. ...
Motley Fool contributor Nicholas Rossolillo joins the channel to share why he owns Doximity (NYSE: DOCS) stock. Healthcare is a lucrative industry, and Doximity aims to help provide large corporations with phenomenal returns on their investments in advertising. Hear all about Ni...
For many small technology companies, 2022 was a revelation that conquering an industry doesn't happen overnight. With the U.S. Federal Reserve aggressively hiking interest rates to cool off inflation and rampant speculation, the realization that profitability does matter is sinking in. ...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...